Status:
COMPLETED
Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients
Lead Sponsor:
Heart Force Medical Inc.
Conditions:
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This study evaluates a new, non-invasive method for screening coronary artery disease (CAD) using seismocardiography (SCG) and gyrocardiography (GCG). These techniques measure chest vibrations caused ...
Eligibility Criteria
Inclusion
- Age 40 years or older.
- Electively scheduled for CAC-CT and have an indication for CCTA
- Suspected coronary artery disease (CAD) based on the presence of:
- At least two cardiovascular risk factors (e.g., hypertension, smoking, diabetes, dyslipidemia, obesity).
- CAD-related symptoms (e.g., chest pain, dyspnea on exertion).
- Suspected congenital coronary abnormalities.
- Ability to provide informed consent.
Exclusion
- Severe cardiac arrhythmias that may interfere with SCG/GCG recordings.
- Decompensated heart failure or severe valvular heart disease.
- Other clinically significant concomitant diseases that may impact study participation.
- History of heart surgery (e.g., recent CABG, valve replacement) that alters chest wall dynamics.
- Contraindications for undergoing CAC-CT or CCTA (e.g., severe renal insufficiency preventing contrast use).
- Inability to remain still in supine or upright sitting positions for testing.
- Inability to provide informed consent due to cognitive or neurological conditions.
Key Trial Info
Start Date :
November 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT06880133
Start Date
November 12 2021
End Date
February 1 2025
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Republic Specialized Scientific-Practical Medical Center of Cardiology (RSPCMCC)
Tashkent, Uzbekistan